MAPT and Alzheimer disease: The relevance of Ca2+ signaling in AD is supported by the fact that Ca2+ alterations were reported in both sporadic (SAD) and familial (FAD) forms of AD and that this can exacerbate Aβ formation and promote tau hyperphosphorylation [35,36,37].